Disease burden of herpes zoster in Korea

被引:38
作者
Choi, Won Suk [1 ]
Noh, Ji Yun [1 ]
Huh, Joong Yeon [1 ]
Jo, Yu Mi [1 ]
Lee, Jacob [2 ]
Song, Joon Young [1 ]
Kim, Woo Joo [1 ]
Cheong, Hee Jin [1 ]
机构
[1] Korea Univ, Coll Med, Div Infect Dis, Dept Internal Med, Seoul 152703, South Korea
[2] Hallym Univ, Sch Med, Dept Internal Med, Seoul, South Korea
关键词
Varicella zoster virus; Herpes zoster; Disease burden; POSTHERPETIC NEURALGIA; COST-EFFECTIVENESS; VARICELLA-ZOSTER; VACCINE; EPIDEMIOLOGY; SEROPREVALENCE; ENGLAND; IMPACT; VIRUS;
D O I
10.1016/j.jcv.2010.01.003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: The occurrence of herpes zoster can deteriorate the quality of life considerably, resulting in high disease burden. While Korea is assumed to have high disease burden of herpes zoster, there has been no researches analyzing this. Objectives: We performed this study to investigate the disease burden of herpes zoster in the Korean population as a whole. Study design: We used the database of the Health Insurance Review & Assessment Service of Korea and analyzed the data of patients who had herpes zoster as a principal diagnosis during the period from 2003 to 2007. We investigated the annual prevalence, rate of clinical visits, rate of hospitalization, and the pattern of medical services use. The socioeconomic burden of herpes zoster was calculated by a conversion into cost. Results: Rates of clinic visits and hospitalizations due to herpes zoster during the 5-year period from 2003 to 2007 were 7.93-12.54 per 1000 population and 0.22-0.32 per 1000 population, respectively. Prevalence rates according to age increased sharply after 50 years and reached a peak at 70 years. The total socioeconomic cost of herpes zoster was $75.9-143.8 million per year, increasing every year by 14-20%. Conclusions: There is a heavy socioeconomic burden due to herpes zoster in Korea and indicate that appropriate policies need to be established to reduce this burden. Additional researches are also necessary to assess the safety, efficacy and cost-effectiveness of a herpes zoster vaccine in the Korean population. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:325 / 329
页数:5
相关论文
共 29 条
[1]  
[Anonymous], SOCIOECONOMIC COSTS
[2]   Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia [J].
Bartoloni, A ;
Bartalesi, F ;
Roselli, M ;
Mantella, A ;
Dini, F ;
Carballo, ES ;
Barron, VP ;
Paradisi, F .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2002, 7 (06) :512-517
[3]   Risk factors for postherpetic neuralgia [J].
Choo, PW ;
Galil, K ;
Donahue, JG ;
Walker, AM ;
Spiegelman, D ;
Platt, R .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (11) :1217-1224
[4]   THE COST OF TREATMENT FOR POSTHERPETIC NEURALGIA IN THE UK [J].
DAVIES, L ;
COSSINS, L ;
BOWSHER, D ;
DRUMMOND, M .
PHARMACOECONOMICS, 1994, 6 (02) :142-148
[5]   The epidemiology of varicella and herpes zoster in The Netherlands:: Implications for varicella zoster virus vaccination [J].
de Melker, Hester ;
Berbers, Guy ;
Hahne, Susan ;
Rumke, Hans ;
van den Hof, Susan ;
de Wit, Ardine ;
Boot, Hein .
VACCINE, 2006, 24 (18) :3946-3952
[6]   Epidemiology and costs of herpes zoster: Background data to estimate the impact of vaccination [J].
Di Legami, Valeria ;
Gianino, Maria Michela ;
Atti, Marta Ciofi Degli ;
Massari, Marco ;
Migliardi, Alessandro ;
Tomba, Gianpaolo Scalia ;
Zotti, Carla .
VACCINE, 2007, 25 (43) :7598-7604
[7]   THE INCIDENCE OF HERPES-ZOSTER [J].
DONAHUE, JG ;
CHOO, PW ;
MANSON, JE ;
PLATT, R .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (15) :1605-1609
[8]   The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales [J].
Edmunds, WJ ;
Brisson, M ;
Rose, JD .
VACCINE, 2001, 19 (23-24) :3076-3090
[9]   Herpes Zoster [J].
Cohen, Jeffrey I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (03) :255-263
[10]  
*HLTH INS RES I, 2007, SURV MED CHARG PAID